SetPoint Medical
PrivateLast Round
Series D
Aug 11, 2025
Est. Valuation
$650M
Total Funding Raised
$379.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SetPoint Medical is a medical technology company that develops implantable bioelectronic devices designed to modulate neuroimmune pathways for treating chronic autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SetPoint Medical Comparables
Compare SetPoint Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 75% | |
| Nēsos Corp. | 72% | |
| Boomerang Medical | 72% | |
SetPoint Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 11, 2025 | ||||
| Series C Extension | Aug 11, 2025 | ||||
| VC Round | Jan 19, 2023 | ||||
| Series C | Jan 19, 2023 | ||||
| Debt | Jul 13, 2021 | ||||
VC Round | Jan 27, 2021 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
BID |
Key People
Founding team and executive leadership
SetPoint Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Runway Growth Capital | Debt, Series C |
| Ascendum Capital | Series D, Series C Extension |
| Sprig Equity | Series D |
| New Enterprise Associates (NEA) | Series D, Series C, Series C Extension, VC Round |
| Topspin Consumer Partners | Series C Extension, Series B, Series C |
| Ally Bridge Group | Series D |
| Gilmartin Capital | Series D, Series C, Series C Extension, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 62% MoM, from 9.4K to 15.1K.
- Jun 24, 2026
Grew 29% QoQ, from 93 to 120 employees.
SetPoint Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SetPoint Medical's valuation, stock price, and market status.